Human Genome Epidemiology Literature Finder
Records 1 - 4 (of 4 Records) |
Query Trace: Osteosarcoma and RFC1[original query] |
---|
Methotrexate in pediatric osteosarcoma: response and toxicity in relation to genetic polymorphisms and dihydrofolate reductase and reduced folate carrier 1 expression. The Journal of pediatrics 2009 May 154 (5): 688-93. Patiño-García Ana, Zalacaín Marta, Marrodán Lucía, San-Julián Mikel, Sierrasesúmaga Lu |
Impact of genetic variants of RFC1, DHFR and MTHFR in osteosarcoma patients treated with high-dose methotrexate. The pharmacogenomics journal 2015 Oct 15 (5): 385-90. Jabeen S, Holmboe L, Alnæs G I G, Andersen A M, Hall K S, Kristensen V |
Single-nucleotide polymorphism profiling by multimodal-targeted next-generation sequencing in methotrexate-resistant and -sensitive human osteosarcoma cell lines. Frontiers in pharmacology 2023 12 14 1294873. Chiara Casotti, Claudia Maria Hattinger, Maria Pia Patrizio, Silvia Luppi, Leonardo Fantoni, Michela Pasello, Katia Scotlandi, Toni Ibrahim, Massimo Ser |
Correlation between gene polymorphism and adverse reactions of high-dose methotrexate in osteosarcoma patients: a systematic review and meta-analysis. World journal of surgical oncology 2024 1 22 (1): 19. Ben Liu, Gang Liu, Binbin Liu, Yao Guo, Ningning Peng, Tiejun |
- Page last reviewed:Feb 1, 2024
- Page last updated:Mar 25, 2024
- Content source: